Title 20

PART 30 SUBPART J

Subpart J - Impairment Benefits Under Part E of EEOICPA

20:1.0.1.3.4.10.152SUBJGRP 152
General Provisions
20:1.0.1.3.4.10.152.1SECTION 30.900
   30.900 Who can receive impairment benefits under Part E
20:1.0.1.3.4.10.152.2SECTION 30.901
   30.901 How does OWCP determine the extent of an employee's impairment that is due to a covered illness contracted through exposure to a toxic substance at a DOE facility or a RECA section 5 facility, as appropriate
20:1.0.1.3.4.10.152.3SECTION 30.902
   30.902 How will OWCP calculate the amount of the award of impairment benefits that is payable under Part E
20:1.0.1.3.4.10.153SUBJGRP 153
Medical Evidence of Impairment
20:1.0.1.3.4.10.153.4SECTION 30.905
   30.905 How may an impairment evaluation be obtained
20:1.0.1.3.4.10.153.5SECTION 30.906
   30.906 Who will pay for an impairment evaluation
20:1.0.1.3.4.10.153.6SECTION 30.907
   30.907 Can an impairment evaluation obtained by OWCP be challenged prior to issuance of the recommended decision
20:1.0.1.3.4.10.153.7SECTION 30.908
   30.908 How will the FAB evaluate new medical evidence submitted to challenge the impairment determination in the recommended decision
20:1.0.1.3.4.10.154SUBJGRP 154
Ratable Impairments
20:1.0.1.3.4.10.154.8SECTION 30.910
   30.910 Will an impairment that cannot be assigned a numerical percentage using the AMA's Guides be included in the impairment rating
20:1.0.1.3.4.10.154.9SECTION 30.911
   30.911 Does maximum medical improvement always have to be reached for an impairment to be included in the impairment rating
20:1.0.1.3.4.10.154.10SECTION 30.912
   30.912 Can a covered Part E employee receive benefits for additional impairment following an award of such benefits by OWCP